Skip to main content
Figure 2 | Cancer Cell International

Figure 2

From: Targeting different types of human meningioma and glioma cells using a novel adenoviral vector expressing GFP-TRAIL fusion protein from hTERT promoter

Figure 2

Expression of GFP-TRAIL in brain tumor cells: (A) Meningioma cells and (B) Glioma cells. The GFP-TRAIL expression after treatment with Ad/gTRAIL was determined by flow cytometric analysis. Cells treated with PBS or Ad/CMV-GFP was used as negative or positive control. On the left side, cell lines; at the top, treatments; and percentages of cells expressing GFP are shown in each panel.

Back to article page

Cancer Cell International

ISSN: 1475-2867

Contact us